ロード中...
Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses
Toll-like receptor (TLR) 7 agonists are effective in topical application for the immunotherapy of skin cancers, but their performance for the systemic treatment of solid tumors is limited by the development of TLR tolerance. In this study, we describe a novel strategy to overcome TLR tolerance and e...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5139637/ https://ncbi.nlm.nih.gov/pubmed/27999742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1232219 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|